Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date AAV Viral Vector Designs For Therapeutic Application Dr. Arkasubhra Ghosh, Director of GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore Recombinant Adeno-associated viral vectors (AAV) has emerged as the most preferred gene delivery modality for long term therapy. A key component of su... 1 month ago | 37 mins Technologies and Platform Approach for Optimizing Downstream Purification... Ashish Saksule at Vertex Pharmaceuticals and Dr Alejandro Becerra at Thermo Fisher Scientific Full title: Technologies and Platform Approach for Optimizing Downstream Purification of Viral Vectors The promising success stories and advancement ... 4 months ago | 103 mins Tailor Your Cell Culture Platform to Achieve Objectives & Scale Requirements Ann Rossi Bilodeau, Senior Bioprocess Applications Scientist, Corning Life Sciences The cell and gene therapy field is rapidly advancing, placing a focus on manufacturing challenges to meet the growing demand. The efficient harvest of... 4 months ago | 24 mins Successful Scale Up of a High Yielding Viral Vector Suspension Platform to 500 L John Ketz, at Andelyn Biosciences, Denis Kole, at Pall Corporation and Benben Song, at Pall Corporation As gene therapies move toward commercialization, the journey to manufacture a high-quality product while achieving economies of scale and reducing fac... 1 year ago | 113 mins Designing production facilities of the future Geoffrey Hodge, Chief Technical Officer at Unum Therapeutics and Gary Pigeau, Ph.D., Director at GE Healthcare Engineered autologous T cell products have proven to be an extremely promising new therapeutic modality, but they are currently time-consuming and cos... 4 years ago | 87 mins Scalable AAV Manufacturing: Addressing Challenges Across the Workflow Chao Yan Liu, Gino Stolfa, Monica Commerford Thermo Fisher Scientific product experts discuss upstream and downstream solutions across the entire workflow. In this webinar, you'll learn about sc... 2 years ago | 85 mins Upstream Viral Vector Manufacturing: Transfections of Adherent Cultures at Scale Cassie-Marie Peigné, PhD, Polyplus-transfection® and Ann Rossi Bilodeau, PhD, Corning Life Sciences Many cell and gene therapy applications are dependent on viral vectors for recombinant gene delivery. Efficient transfection of a large biomass of cel... 2 years ago | 44 mins Material Requirements to Support Gene Therapy Development Clare Blue, Director of Analytical Development at Biogen and James Wilkinson, VP of Sales and Customer Success at Refeyn Manufacturing processes for gene therapy products are generally low yielding compared to production processes for other biologics. The material requir... 1 year ago | 73 mins Corning® Ascent® FBR - Innovative technology for scalable adherent cell culture Sascha Kiesslich, PhD, Corning Life Sciences Advances in the science of gene and cell therapies have created rapid growth in the industry, with the common challenge of producing therapeutic cells... 11 months ago | 34 mins Multiply Your Cells, Not Your Work: How to Upscale Adherent Cells [ENG. VERSION] Constanza Curotto The Life Sciences Rendez-vous : Bioprocess, Adherent Cells - PART 1/3. Attend our new compact webinars series (30min) in your local language. See Par... 3 years ago | 25 mins